当代医学
噹代醫學
당대의학
CHINA CONTEMPORARY MEDICINE
2013年
3期
9-11
,共3页
闫晓红%刘尧%汪华%耿熠
閆曉紅%劉堯%汪華%耿熠
염효홍%류요%왕화%경습
鸦胆子油乳%FOLFIRI%晚期结直肠癌%化学治疗%中医治疗
鴉膽子油乳%FOLFIRI%晚期結直腸癌%化學治療%中醫治療
아담자유유%FOLFIRI%만기결직장암%화학치료%중의치료
Fructus Brucea Oil Emulsion%FOLFIRI%Advanced Colorectal Cancer%Chemotherapy%Chinese Medicine Therapy
目的观察鸦胆子油乳联合FOLFIRI方案化疗与单纯FOLFIRI方案化疗对晚期结直肠癌患者的疗效以及对生活质量的影响.方法将109例患有晚期结直肠癌患者随机分为两组:治疗组,在FOLFIRI化疗方案基础上加用鸦胆子油乳治疗;对照组,单纯接受FOLFIRI方案化疗.对109例患者追踪2个月,观察并比较患者的疗效、体力状况、生活质量、不良反应等方面的差异.结果在FOLFIRI方案化疗基础上加用鸦胆子油乳治疗后,患者经中医症候评定疗效与单纯FOLFIRI方案化疗相比差异具有统计学意义(P<0.05);在改善患者体力状况、生活质量方面均优于单纯FOLFIRI方案化疗(P<0.05);在化疗所引发的白细胞、血红蛋白和血小板降低等不良反应发生率方面低于单纯FOLFIRI方案化疗组(P<0.05).结论鸦胆子油乳联合FOLFIRI方案化疗治疗晚期结直肠癌不仅可以起到化疗增效的作用,而且能够明显提高患者生活质量和体力状况,降低化疗引发的不良反应,这一联合治疗方案可以在临床治疗中推广.
目的觀察鴉膽子油乳聯閤FOLFIRI方案化療與單純FOLFIRI方案化療對晚期結直腸癌患者的療效以及對生活質量的影響.方法將109例患有晚期結直腸癌患者隨機分為兩組:治療組,在FOLFIRI化療方案基礎上加用鴉膽子油乳治療;對照組,單純接受FOLFIRI方案化療.對109例患者追蹤2箇月,觀察併比較患者的療效、體力狀況、生活質量、不良反應等方麵的差異.結果在FOLFIRI方案化療基礎上加用鴉膽子油乳治療後,患者經中醫癥候評定療效與單純FOLFIRI方案化療相比差異具有統計學意義(P<0.05);在改善患者體力狀況、生活質量方麵均優于單純FOLFIRI方案化療(P<0.05);在化療所引髮的白細胞、血紅蛋白和血小闆降低等不良反應髮生率方麵低于單純FOLFIRI方案化療組(P<0.05).結論鴉膽子油乳聯閤FOLFIRI方案化療治療晚期結直腸癌不僅可以起到化療增效的作用,而且能夠明顯提高患者生活質量和體力狀況,降低化療引髮的不良反應,這一聯閤治療方案可以在臨床治療中推廣.
목적관찰아담자유유연합FOLFIRI방안화료여단순FOLFIRI방안화료대만기결직장암환자적료효이급대생활질량적영향.방법장109례환유만기결직장암환자수궤분위량조:치료조,재FOLFIRI화료방안기출상가용아담자유유치료;대조조,단순접수FOLFIRI방안화료.대109례환자추종2개월,관찰병비교환자적료효、체력상황、생활질량、불량반응등방면적차이.결과재FOLFIRI방안화료기출상가용아담자유유치료후,환자경중의증후평정료효여단순FOLFIRI방안화료상비차이구유통계학의의(P<0.05);재개선환자체력상황、생활질량방면균우우단순FOLFIRI방안화료(P<0.05);재화료소인발적백세포、혈홍단백화혈소판강저등불량반응발생솔방면저우단순FOLFIRI방안화료조(P<0.05).결론아담자유유연합FOLFIRI방안화료치료만기결직장암불부가이기도화료증효적작용,이차능구명현제고환자생활질량화체력상황,강저화료인발적불량반응,저일연합치료방안가이재림상치료중추엄.
Objective To observe the differences between FOLFIRI chemotherapy and Fructus Brucea Oil Emulsion combination with chemotherapy treatment for the advanced colorectal cancer (CRC) patients’ therapeutic effect and the quality of life. Methods 109 cases advanced CRC patients were randomly divided into chemotherapy group and Fructus Brucea Oil Emulsion combination with chemotherapy group. Chemotherapy group was treated with FOLFIRI scheme. The other group was treated with Fructus Brucea Oil Emulsion and FOLFIRI scheme. All patients were observed for two months and analyzed the differences in the therapeutic effect, body quality score, quality of life score and toxic effect. Results Fructus Brucea Oil Emulsion combination with FOLFIRI scheme is superior to FOLFIRI scheme in the therapeutic effect and improvement of body quality score, quality of life score and the decrease of toxic effect (P<0.05). Conclusion Fructus Brucea Oil Emulsion combination with FOLFIRI scheme could increase the therapeutic effect, improve the life quality and body quality of the patients and decrease the incidence of toxic effect induced by chemotherapy.